Showing results (41-50 of 111) with videos related to
Sort By:
Pageof 12
EMBO Reports|January 29, 2005
Strength of TRAF6 signalling determines osteoclastogenesisYuho Kadono, Fumihiko Okada, Claire Perchonock, et al.BMB Reports|February 8, 2026
CaMKIV negatively regulates osteoblast differentiation by modulating c-Fos and NFATc1 signaling: an in vitro and in vivo mechanistic studyJung Ha Kim, Kabsun Kim, Inyoung Kim, et al.The Journal of Biological Chemistry|April 2, 2009
Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiationTaesoo Kim, Kabsun Kim, Seoung Hoon Lee, et al.Molecules and Cells|December 19, 2014
MicroRNA-26a regulates RANKL-induced osteoclast formationKabsun Kim, Jung Ha Kim, Inyoung Kim, et al.Connective Tissue Research|September 4, 2003
The role of RANKL (TRANCE/TNFSF11), a tumor necrosis factor family member, in skeletal development: effects of gene knockout and transgenic rescuePaul R Odgren, Nacksung Kim, Carole A MacKay, et al.Annual Review of Immunology|March 23, 2006
Osteoimmunology: interplay between the immune system and bone metabolismMatthew C Walsh, Nacksung Kim, Yuho Kadono, et al.Molecular Medicine (Cambridge, Mass.)|April 18, 2025
Tripartite motif-containing 27 negatively regulates NF-κB activation in bone remodelingKabsun Kim, Jung Ha Kim, Inyoung Kim, et al.Experimental & Molecular Medicine|September 27, 2019
Adaptor protein CrkII negatively regulates osteoblast differentiation and function through JNK phosphorylationJung Ha Kim, Kabsun Kim, Inyoung Kim, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2007
Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptorKabsun Kim, Junwon Lee, Jung Ha Kim, et al.Molecules and Cells|September 17, 2009
Silibinin inhibits osteoclast differentiation mediated by TNF family membersJung Ha Kim, Kabsun Kim, Hye Mi Jin, et al.Pageof 12